Status:
COMPLETED
Iron Supplementation of Lead-exposed Infants
Lead Sponsor:
Cornell University
Collaborating Sponsors:
Thrasher Research Fund
Conditions:
Lead Toxicity
Eligibility:
All Genders
6-18 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the efficacy of iron (12.5 mg as ferrous sulfate) and placebo given for 6 months in preventing the elevation of blood lead concentration in children 6-9 months ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Infants included if gestational age \>36 weeks, birth weight \> 2500g, no chronic illness, blood lead concentration \<10 mcg/dL, hemoglobin \>9 g/dL, zinc protoporphyrin \>90 mmol/mol heme
- Mothers included if 18 years or older
- Exclusion criteria:
- Hemoglobin \>11.5 g/dL
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00374790
Start Date
October 1 2006
End Date
July 1 2008
Last Update
May 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic for Environmnetal Contaminants
Montevideo, Uruguay